Clinical prognostic value of secondary mitral valve regurgitation

Yan Topilski, Francesco Grigioni, Maurice E Sarano

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Functional mitral regurgitation (FMR) is a common complication of ischemic heart disease and severe dilated cardiomyopathy, and results from left ventricle (LV) deformation, tethering of the structurally normal mitral leafl ets and decreased LV force to close them (Enriquez-Sarano et al., Lancet 18;373(9672):1382–94, 2009). It is still disputed whether FMR is the primary cause for the poor outcome associated with it, or just a surrogate marker for worse left-ventricular dysfunction. However, the clear association of severe FMR with worse outcomes, independent of ejection fraction, age, and clinical presentation, suggests that the regurgitation is indeed causal of poor outcome. The prognostic role of mitral regurgitation is now substantiated by results from studies of patients with acute (Lamas et al., Circulation 96(3):827–33, 1997; Tcheng et al., Ann Intern Med 117(1):18–24, 1992), or chronic myocardial infarction (Bursi et al., Circulation 111(3):295–301, 2005; Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003), dilated cardiomyopathy (Rossi et al., Heart 97(20):1675–80, 2011), clinical trials (Lamas et al., Circulation 96(3):827–33, 1997) and population studies (Bursi et al., Circulation 111(3):295– 301, 2005). Effective regurgitant orifice (ERO) and the change in ERO during exercise are considered the best prognostic parameters in patients with FMR (Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003).

Original languageEnglish (US)
Title of host publicationSecondary Mitral Valve Regurgitation
PublisherSpringer-Verlag London Ltd
Pages13-18
Number of pages6
ISBN (Print)9781447164883, 9781447164876
DOIs
StatePublished - Jan 1 2015

Fingerprint

Mitral Valve Insufficiency
Dilated Cardiomyopathy
Heart Ventricles
Left Ventricular Dysfunction
Myocardial Ischemia
Biomarkers
Myocardial Infarction
Clinical Trials
Exercise
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Topilski, Y., Grigioni, F., & Sarano, M. E. (2015). Clinical prognostic value of secondary mitral valve regurgitation. In Secondary Mitral Valve Regurgitation (pp. 13-18). Springer-Verlag London Ltd. https://doi.org/10.1007/9781447164883_3

Clinical prognostic value of secondary mitral valve regurgitation. / Topilski, Yan; Grigioni, Francesco; Sarano, Maurice E.

Secondary Mitral Valve Regurgitation. Springer-Verlag London Ltd, 2015. p. 13-18.

Research output: Chapter in Book/Report/Conference proceedingChapter

Topilski, Y, Grigioni, F & Sarano, ME 2015, Clinical prognostic value of secondary mitral valve regurgitation. in Secondary Mitral Valve Regurgitation. Springer-Verlag London Ltd, pp. 13-18. https://doi.org/10.1007/9781447164883_3
Topilski Y, Grigioni F, Sarano ME. Clinical prognostic value of secondary mitral valve regurgitation. In Secondary Mitral Valve Regurgitation. Springer-Verlag London Ltd. 2015. p. 13-18 https://doi.org/10.1007/9781447164883_3
Topilski, Yan ; Grigioni, Francesco ; Sarano, Maurice E. / Clinical prognostic value of secondary mitral valve regurgitation. Secondary Mitral Valve Regurgitation. Springer-Verlag London Ltd, 2015. pp. 13-18
@inbook{a7156944d43a4da18781569de97df102,
title = "Clinical prognostic value of secondary mitral valve regurgitation",
abstract = "Functional mitral regurgitation (FMR) is a common complication of ischemic heart disease and severe dilated cardiomyopathy, and results from left ventricle (LV) deformation, tethering of the structurally normal mitral leafl ets and decreased LV force to close them (Enriquez-Sarano et al., Lancet 18;373(9672):1382–94, 2009). It is still disputed whether FMR is the primary cause for the poor outcome associated with it, or just a surrogate marker for worse left-ventricular dysfunction. However, the clear association of severe FMR with worse outcomes, independent of ejection fraction, age, and clinical presentation, suggests that the regurgitation is indeed causal of poor outcome. The prognostic role of mitral regurgitation is now substantiated by results from studies of patients with acute (Lamas et al., Circulation 96(3):827–33, 1997; Tcheng et al., Ann Intern Med 117(1):18–24, 1992), or chronic myocardial infarction (Bursi et al., Circulation 111(3):295–301, 2005; Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003), dilated cardiomyopathy (Rossi et al., Heart 97(20):1675–80, 2011), clinical trials (Lamas et al., Circulation 96(3):827–33, 1997) and population studies (Bursi et al., Circulation 111(3):295– 301, 2005). Effective regurgitant orifice (ERO) and the change in ERO during exercise are considered the best prognostic parameters in patients with FMR (Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003).",
author = "Yan Topilski and Francesco Grigioni and Sarano, {Maurice E}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/9781447164883_3",
language = "English (US)",
isbn = "9781447164883",
pages = "13--18",
booktitle = "Secondary Mitral Valve Regurgitation",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Clinical prognostic value of secondary mitral valve regurgitation

AU - Topilski, Yan

AU - Grigioni, Francesco

AU - Sarano, Maurice E

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Functional mitral regurgitation (FMR) is a common complication of ischemic heart disease and severe dilated cardiomyopathy, and results from left ventricle (LV) deformation, tethering of the structurally normal mitral leafl ets and decreased LV force to close them (Enriquez-Sarano et al., Lancet 18;373(9672):1382–94, 2009). It is still disputed whether FMR is the primary cause for the poor outcome associated with it, or just a surrogate marker for worse left-ventricular dysfunction. However, the clear association of severe FMR with worse outcomes, independent of ejection fraction, age, and clinical presentation, suggests that the regurgitation is indeed causal of poor outcome. The prognostic role of mitral regurgitation is now substantiated by results from studies of patients with acute (Lamas et al., Circulation 96(3):827–33, 1997; Tcheng et al., Ann Intern Med 117(1):18–24, 1992), or chronic myocardial infarction (Bursi et al., Circulation 111(3):295–301, 2005; Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003), dilated cardiomyopathy (Rossi et al., Heart 97(20):1675–80, 2011), clinical trials (Lamas et al., Circulation 96(3):827–33, 1997) and population studies (Bursi et al., Circulation 111(3):295– 301, 2005). Effective regurgitant orifice (ERO) and the change in ERO during exercise are considered the best prognostic parameters in patients with FMR (Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003).

AB - Functional mitral regurgitation (FMR) is a common complication of ischemic heart disease and severe dilated cardiomyopathy, and results from left ventricle (LV) deformation, tethering of the structurally normal mitral leafl ets and decreased LV force to close them (Enriquez-Sarano et al., Lancet 18;373(9672):1382–94, 2009). It is still disputed whether FMR is the primary cause for the poor outcome associated with it, or just a surrogate marker for worse left-ventricular dysfunction. However, the clear association of severe FMR with worse outcomes, independent of ejection fraction, age, and clinical presentation, suggests that the regurgitation is indeed causal of poor outcome. The prognostic role of mitral regurgitation is now substantiated by results from studies of patients with acute (Lamas et al., Circulation 96(3):827–33, 1997; Tcheng et al., Ann Intern Med 117(1):18–24, 1992), or chronic myocardial infarction (Bursi et al., Circulation 111(3):295–301, 2005; Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003), dilated cardiomyopathy (Rossi et al., Heart 97(20):1675–80, 2011), clinical trials (Lamas et al., Circulation 96(3):827–33, 1997) and population studies (Bursi et al., Circulation 111(3):295– 301, 2005). Effective regurgitant orifice (ERO) and the change in ERO during exercise are considered the best prognostic parameters in patients with FMR (Grigioni et al., Circulation 103(13):1759–64, 2001; Lancellotti et al., Circulation 108(14):1713–7, 2003).

UR - http://www.scopus.com/inward/record.url?scp=84955348019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955348019&partnerID=8YFLogxK

U2 - 10.1007/9781447164883_3

DO - 10.1007/9781447164883_3

M3 - Chapter

AN - SCOPUS:84955348019

SN - 9781447164883

SN - 9781447164876

SP - 13

EP - 18

BT - Secondary Mitral Valve Regurgitation

PB - Springer-Verlag London Ltd

ER -